A device for releasing a therapeutic agent in the body space in the form of a prosthetic joint implant having a first portion such as a stemmed portion for contacting bone tissue in an intramedullary canal of a long bone. The implant has a second portion which extends into the body space such as a j
A device for releasing a therapeutic agent in the body space in the form of a prosthetic joint implant having a first portion such as a stemmed portion for contacting bone tissue in an intramedullary canal of a long bone. The implant has a second portion which extends into the body space such as a joint space. The joint component contains a reservoir filled with a bioabsorbable/resorbable polymer which includes a therapeutic agent. The reservoir is open or in contact with the joint space as the body fluid diffuses in and out of the polymeric device it carries the drug into the joint space.
대표청구항▼
1. A prosthetic joint implant device for releasing a therapeutic agent into a joint space comprising: (a) a stem component for insertion into a bone, contiguous with(b) a joint component for extension into a fluid-containing joint space; and(c) a cavity enclosed within the stem and joint components
1. A prosthetic joint implant device for releasing a therapeutic agent into a joint space comprising: (a) a stem component for insertion into a bone, contiguous with(b) a joint component for extension into a fluid-containing joint space; and(c) a cavity enclosed within the stem and joint components that (i) extends from the stem component into the joint component, having an opening in the joint component and (ii) serves as a reservoir, containing a bioresorbable polymer comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof; wherein the device is configured such that, when at its intended location in a subject, the opening of the reservoir is at a position in the joint component that extends beyond the bone and into the joint space, such that the opening allows joint fluid to diffuse into the device, providing sustained release of agent. 2. The device of claim 1, wherein the amount of therapeutic agent in the bioresorbable polymer is between 40 and 60 percent. 3. The device of claim 1, wherein the bioresorbable polymer is poly-(DL Lactide/Gylcolide co-polymer. 4. The device of claim 1, wherein the therapeutic agent comprises an analgesic selected from the group consisting of bupivacaine, ropivacaine, dibucaine, etidocaine, tetracaine, lidocaine, and combinations thereof. 5. The device of claim 3, wherein the therapeutic agent comprises an analgesic selected from the group consisting of bupivacaine, ropivacaine, dibucaine, etidocaine, tetracaine, lidocaine, and combinations thereof. 6. The device of claim 4, wherein the therapeutic agent comprises bupivacaine. 7. The device of claim 5, wherein the therapeutic agent comprises bupivacaine. 8. The device of claim 4, wherein the therapeutic agent further comprises an antibiotic. 9. The device of claim 5, wherein the therapeutic agent further comprises an antibiotic. 10. A prosthetic joint implant device for releasing a therapeutic agent into a hip joint space comprising: (a) a stem component for insertion into a femur, contiguous with(b) a joint component for extension into a fluid-containing hip joint space, continuous with a prosthetic femoral head; and(c) a cavity enclosed within the stem and joint components that (i) extends from the stem component into the joint component, having an opening in the joint component and (ii) serves as a reservoir, containing a bioresorbable polymer comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof; wherein the device is configured such that, when at its intended location in a subject, the opening of the reservoir is at a position in the joint component that extends beyond the bone and into the joint space, such that the opening allows joint fluid to diffuse into the device, providing sustained release of agent. 11. The device of claim 10, wherein the amount of therapeutic agent in the bioresorbable polymer is between 40 and 60 percent. 12. The device of claim 10, wherein the bioresorbable polymer is poly-(DL Lactide/Gylcolide co-polymer. 13. The device of claim 10, wherein the therapeutic agent comprises an analgesic selected from the group consisting of bupivacaine, ropivacaine, dibucaine, etidocaine, tetracaine, lidocaine, and combinations thereof. 14. The device of claim 10, wherein the therapeutic agent comprises bupivacaine. 15. The device of claim 13, wherein the therapeutic agent further comprises an antibiotic. 16. A prosthetic joint implant device for releasing a therapeutic agent into a knee joint space comprising: (a) a stem component for insertion into a femur or tibia, contiguous with(b) a joint component for extension into a fluid-containing knee joint space; and(c) a cavity enclosed within the stem and joint components that (i) extends from the stem component into the joint component, having an opening in the joint component and (ii) serves as a reservoir, containing a bioresorbable polymer comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof; wherein the device is configured such that, when at its intended location in a subject, the opening of the reservoir is at a position in the joint component that extends beyond the bone and into the joint space, such that the opening allows joint fluid to diffuse into the device, providing sustained release of agent. 17. The device of claim 16, wherein the amount of therapeutic agent in the bioresorbable polymer is between 40 and 60 percent. 18. The device of claim 16, wherein the bioresorbable polymer is poly-(DL Lactide/Gylcolide co-polymer. 19. The device of claim 16, wherein the therapeutic agent comprises an analgesic selected from the group consisting of bupivacaine, ropivacaine, dibucaine, etidocaine, tetracaine, lidocaine, and combinations thereof. 20. The device of claim 16, wherein the therapeutic agent comprises bupivacaine. 21. The device of claim 19, wherein the therapeutic agent further comprises an antibiotic. 22. A method for supplying a therapeutic agent to a joint space of a subject recipient of a joint implant, comprising: (i) introducing, into the joint of a subject in need of such treatment, a joint implant device comprising:(a) a stem component for insertion into a bone, contiguous with(b) a joint component for extension into a fluid-containing joint space; and(c) a cavity enclosed within the stem and joint components that (i) extends from the stem component into the joint component, having an opening in the joint component and (ii) serves as a reservoir, containing a bioresorbable polymer comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof, and(ii) positioning the stem component in the bone such that the opening of the reservoir is located beyond the bone within the joint space, such that the opening allows joint fluid to diffuse into the device and provides sustained release of therapeutic agent. 23. The method of claim 22, wherein the joint is a hip joint. 24. The method of claim 22, wherein the joint is a knee joint. 25. The method of claim 22, wherein the amount of therapeutic agent in the bioresorbable polymer is between 40 and 60 percent. 26. The method of claim 22, wherein the bioresorbable polymer is poly-(DL Lactide/Gylcolide co-polymer. 27. The method of claim 22, wherein the therapeutic agent comprises an analgesic selected from the group consisting of bupivacaine, ropivacaine, dibucaine, etidocaine, tetracaine, lidocaine, and combinations thereof. 28. The method of claim 22, wherein the therapeutic agent comprises bupivacaine. 29. The method of claim 27, wherein the therapeutic agent further comprises an antibiotic. 30. The device of claim 1, further comprising a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 31. The device of claim 10, further comprising a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 32. The device of claim 16, further comprising a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 33. The device of claim 16, further comprising a tibial baseplate and a bioresorbable polymer around the outside of said tibial baseplate, where the bioresorbable polymer around said baseplate comprises a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 34. The method of claim 22 wherein the device further comprises a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 35. The method of claim 23 wherein the device further comprises a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 36. The method of claim 24 wherein the device further comprises a coating around non-load bearing surfaces of the device that extend into or are exposed to the joint space, said coating comprising a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof. 37. The method of claim 24 wherein the device further comprises a tibial baseplate and a bioresorbable polymer around the outside of said tibial baseplate, where the bioresorbable polymer around said baseplate comprises a therapeutic agent selected from the group consisting of an analgesic, an antibiotic, and a combination thereof.
Domb Abraham J. (Baltimore MD) Shikani Alain (Baltimore MD) Haffer Andrew S. T. (Baltimore MD) Maniar Manoj (Baltimore MD), Anti-infective and anti-inflammatory releasing systems for medical devices.
Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
D\Amore Patricia (Brookline MA) Leong Kam W. (Cambridge MA) Langer Robert S. (Somerville MA), Bioerodible articles useful as implants and prostheses having predictable degradation rates.
Wise Donald L. ; Gresser Joseph D. ; Trantolo Debra J. ; Hsu Yung-Yueh, Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same.
Duncan Clive P. (Vancouver CAX) Breault Martine J. (Vancouver CAX) Beauchamp Christ P. (Vancouver CAX) Paris Nancy J. (Vancouver CAX), Flexible mold for forming composite of a hip replacement component and a bone cement sleeve.
Paul Goldenheim ; Donna Donigi-Gale ; Kevin Burton ; Mohammed Shameem ; Amol Ketkar ; Mark Chasin ; Richard Maskiewicz, Formulations and methods for providing prolonged local anesthesia.
Ashton Paul ; Patchell Roy A. ; Cooper Jon ; Young Byron A., Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body.
Ashton Paul ; Crooks Peter Anthony ; Cynkowski Tadeusz ; Cynkowska Grazyna ; Guo Hone, Means to achieve sustained release of synergistic drugs by conjugation.
Vert Michel (Mont-Saint-Aignan FRX) Mauduit Jacques (Bacqueville En Caux FRX) Bukh Niels (Hellerup DKX), Polylactic acid-based implant susceptible of bioresorption containing and antibiotic.
Kaplan Donald S. (7 White Oak La. Weston CT 06883) Muth Ross R. (97 Clearview Dr. R.D. 2 CT 06804), Polymers for injection molding of absorbable surgical devices.
Rueger David C. (Hopkinton MA) Kuberasampath Thangavel (Medway MA) Oppermann Hermann (Medway MA) Ozkaynak Engin (Milford MA), Prosthetic devices having enhanced osteogenic properties.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.